PTCH1 and neoplasm: miR‐212‐3p was shown by Chen‐chao Ma and colleagues to promote PDAC progression and metastasis via modulation of the Hh signalling pathway receptor PTCH1.16 In the case of NSCLC, Yuan Li found miR‐212‐3p may act as an oncogene to promote cell proliferation and other aggressive behaviour of tumour cells by acting on PTCH1.76